The product development pathway

The product development pathway

New, cheap and simple to use health products are needed if poor countries are to combat HIV, TB, malaria and other diseases. The UK's DFID and other donors are making substantial investments in health research, but research to develop new healthproducts is an expensive and complex process. It involves many different players, multiple sources of funding and a range of investment strategies. This makes it difficult for DFID to identify how it can use relatively small resources to best effect.

During the early stages of the wider GHP study commissioned by DFID in 2004, a need was identified to produce a visual representation of the processes that must occur to move a health product from original concept to tangible products being used in a developing country setting. The requirement was a user-friendly tool to aid both advocacy and analysis. The following Product Development Pathway has been developed  using HIV, TB and malaria as the disease examples.

The diagram identifies the different processes required to generate new products, and the barriers and linkages between the various processes. It also identifies “who is doing what” at each stage of the research process.

  1. How good is this research?

    Assessing the quality of research can be a tricky business. This blog from our editor offers some tools and tips.